Risk Gene Identification
Risk Gene Identification - Related Videos
08:17
VIGS-Mediated Forward Genetics Screening for Identification of Genes Involved in Nonhost Resistance
0 Views •
Cited by 22 •
2013
Virus-induced gene silencing is an useful tool for identifying genes involved in nonhost resistance of plants. We demonstrate the use of bacterial pathogens expressing GFPuv in identifying gene silenced plants susceptible to nonhost pathogens. This approach is easy, fast and facilitates large scale screening and similar protocol can be applied to studying various other plant-microbe interactions.
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
0 Views •
Cited by 40 •
2014
The NICU Network Neurobehavioral Scale (NNNS) was developed as an assessment for the at-risk infant. The purpose of this article is to describe the NNNS, provide video examples of the NNNS procedures and discuss the ways in which the exam has been used.
06:34
Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS
0 Views •
Cited by 29 •
2016
Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) and molecular techniques (16S rRNA gene sequencing) permit the identification of rare bacterial pathogens in routine diagnostics. The goal of this protocol lies in the combination of both techniques which leads to more accurate and reliable data.
08:57
Identification of Novel Genes Associated with Alginate Production in Pseudomonas aeruginosa Using Mini-himar1 Mariner Transposon-mediated Mutagenesis
0 Views •
Cited by 13 •
2014
Here we describe a protocol using the mini-himar1 mariner transposon-mediated mutagenesis for generating a high-density insertion mutant library to screen, isolate and identify novel alginate regulators in the prototypic Pseudomonas aeruginosa strain PAO1.
01:35
Types of Risk: Systematic Risk
0 Views •
2024
Systematic risk is inherent to the market and reflects the impact of economic, financial, and geopolitical factors. It affects the entire market rather than specific stocks or industries. This type of risk is unavoidable and cannot be mitigated through diversification. Market risk refers to the possibility that the overall stock market will decline, impacting the value of all investments. This risk is often driven by macroeconomic factors such as economic recessions, financial crises, or global...
FAQs
Statistical analysis helps separate potentially meaningful genetic associations from patterns that could arise by chance. After researchers compare variation in affected and unaffected individuals, they evaluate how strongly a variant tracks with the trait or disease and whether the observed relationship is unlikely to be random. This step gives findings a more defensible basis for biological interpretation and risk assessment.
Genome-wide association studies, linkage analysis, and DNA sequencing can be used as complementary approaches rather than interchangeable labels. Together, they expand how researchers examine genetic variation associated with disease or traits, helping connect statistical associations with questions about inherited disorders, sequence variation, and the biological pathways involved.
Once a variant is associated with a trait or disease, researchers can examine whether it helps illuminate a biological pathway. This matters because pathways provide a framework for connecting genetic findings to disease mechanisms rather than treating each association as an isolated result. The resulting insight can guide more targeted prevention or treatment strategies.
A practical investigation moves from selecting an approach to examining genetic variation in affected and unaffected individuals, followed by statistical evaluation of the observed associations. Researchers may use genome-wide association studies, linkage analysis, or DNA sequencing at this stage. Interpreting the results then links statistically supported findings to risk assessment and further genetic research.
Findings can reveal genetic variants relevant to inherited disorders and help researchers connect those variants with broader disease mechanisms or biological pathways. This information supports genetic research by clarifying which observations deserve further study, while also contributing to assessment of how genetic variation relates to disease likelihood.
Identified variants are not relevant only to a single disease-focused comparison; they can also inform studies of population variation. This broader context extends the value of risk gene identification beyond one trait, supporting genetics research on variation and its relationship to disease risk.
Variants associated with disease or traits can be examined in the context of how individuals respond to drugs, making drug response an application of risk gene identification. This connection broadens the use of genetic findings beyond disease likelihood and can support development of more targeted treatment strategies.